Cargando…
Inhibition of Cell Proliferation by an Anti-EGFR Aptamer
Aptamers continue to receive interest as potential therapeutic agents for the treatment of diseases, including cancer. In order to determine whether aptamers might eventually prove to be as useful as other clinical biopolymers, such as antibodies, we selected aptamers against an important clinical t...
Autores principales: | Li, Na, Nguyen, Hong Hanh, Byrom, Michelle, Ellington, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110755/ https://www.ncbi.nlm.nih.gov/pubmed/21687663 http://dx.doi.org/10.1371/journal.pone.0020299 |
Ejemplares similares
-
Aptamers as therapeutics
por: Keefe, Anthony D., et al.
Publicado: (2010) -
Aptamer Antagonists of Myelin-Derived Inhibitors Promote Axon Growth
por: Wang, Yuxuan, et al.
Publicado: (2010) -
Aptamers in Education: Undergraduates Make Aptamers and Acquire 21st Century Skills Along the Way
por: Stovall, Gwendolyn M., et al.
Publicado: (2019) -
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
por: Thomas, Brian J., et al.
Publicado: (2023) -
Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)